Treatment for Basal Cell Carcinomas (BCCs) in Gorlin Syndrome Patients

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Treatment for Basal Cell Carcinomas (BCCs) in Gorlin Syndrome Patients trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

CompletedPhase 2

NCT00961896

A Trial to Evaluate the Safety, Local Tolerability, Pharmacokinetics and Pharmacodynamics of LDE225 on Skin Basal Cell C…

Part I was a double-blind, randomized, vehicle-controlled Proof of Concept (PoC) study to evaluate the safety, local tolerability, pharmacokinetics and pharmaco…

Austria, Switzerland18 participantsStarted 2009-07

Treatment: Vehicle, LDE225 0.25%